COVIGRO: Impact of COVID-19 and the SARS-CoV-2 vaccine on placental and fetal development
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 459222
Grant search
Key facts
Disease
COVID-19Start & end year
2021Known Financial Commitments (USD)
$211,488.24Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Bujold Emmanuel, Boivin GuyResearch Location
CanadaLead Research Institution
Université LavalResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Adverse events associated with immunizationSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
Adults (18 and older)Vulnerable Population
Pregnant womenOccupations of Interest
Unspecified
Abstract
The scientific data on the impact of COVID-19 on pregnancy are limited but suggest an increase in complications such as preterm birth and preeclampsia. At the same time, the scientific data are limited regarding the effectiveness of the COVID-19 vaccine given during pregnancy and whether gestational age can influence its effectiveness and/or impact on the outcome of the pregnancy. We will compare two cohorts of pregnant women, one recruited before the pandemic (2017-2018) and one recruited during the 2020-2021 pandemic. Using blood tests collected at different times during pregnancy, and using questionnaires, we will be able to establish whether the patient was infected with COVID-19 and whether she received the vaccine. We will evaluate the effect of COVID-19 on placental development and fetal development, as well as on the rate of complications. Finally, we will evaluate whether the vaccine received during pregnancy is as effective as the vaccine received before or after pregnancy.